Rathan K S Shetty1, Satheesh Kumar Bhandary2, Arunava Kali3. 1. Assistant Professor, Department of Otorhinolaryngology, Mahatma Gandhi Medical College & Research Institute , Pondicherry, India . 2. Professor & HOD, Department of Otorhinolaryngology, K S Hegde Medical Academy , Mangalore, Karnataka, India . 3. Assistant Professor, Department of Microbiology, Mahatma Gandhi Medical College & Research Institute , Pondicherry, India .
Abstract
BACKGROUND: Head and neck neoplasia is a major form of cancer in India, accounting for 30% of all cancers which occur in males and 11% of cancers which occur in females. Elevated serum L-fucose glycoprotein levels have been reported to be associated with neoplastic conditions involving various sites. Therefore, monitoring serum/tissue L-fucose glycoprotein levels could be a promising approach for the early diagnosis and prognosis of head neck cancers. AIM: This study was carried out to determine the significance of serum L-fucose levels in head and neck malignancies. SETTINGS AND DESIGN: This comparative study was carried out at a tertiary care hospital in South India. MATERIAL AND METHODS: Serum L-fucose glycoprotein levels were estimated in 50 patients with histopathologically confirmed head and neck malignancies and they were compared with those of 50 age- and sex-matched healthy controls. STATISTICAL ANALYSIS USED: Student's t-test was used to compare L-fucose glycoprotein levels in study and control groups. RESULTS: Most common site of the primary tumour in the current study was oral cavity, followed by larynx, hypopharynx and oropharynx respectively. Comparison of glycoprotein L-fucose in two groups showed more than a two-fold rise in serum fucose levels in cases as compared to the those in controls, with mean values of 11.33±7.39 and 4.74±1.55 mg% in cases and controls respectively. There was no relationship between serum fucose levels and age, sex and tumour differentiation. CONCLUSION: Serum glycoprotein L-fucose levels can be used as an effective biochemical indicator in conjunction with clinical diagnostic procedures in head and neck neoplasia and they may be useful for monitoring recurrences.
BACKGROUND: Head and neck neoplasia is a major form of cancer in India, accounting for 30% of all cancers which occur in males and 11% of cancers which occur in females. Elevated serum L-fucose glycoprotein levels have been reported to be associated with neoplastic conditions involving various sites. Therefore, monitoring serum/tissue L-fucose glycoprotein levels could be a promising approach for the early diagnosis and prognosis of head neck cancers. AIM: This study was carried out to determine the significance of serum L-fucose levels in head and neck malignancies. SETTINGS AND DESIGN: This comparative study was carried out at a tertiary care hospital in South India. MATERIAL AND METHODS: Serum L-fucose glycoprotein levels were estimated in 50 patients with histopathologically confirmed head and neck malignancies and they were compared with those of 50 age- and sex-matched healthy controls. STATISTICAL ANALYSIS USED: Student's t-test was used to compare L-fucose glycoprotein levels in study and control groups. RESULTS: Most common site of the primary tumour in the current study was oral cavity, followed by larynx, hypopharynx and oropharynx respectively. Comparison of glycoprotein L-fucose in two groups showed more than a two-fold rise in serum fucose levels in cases as compared to the those in controls, with mean values of 11.33±7.39 and 4.74±1.55 mg% in cases and controls respectively. There was no relationship between serum fucose levels and age, sex and tumour differentiation. CONCLUSION: Serum glycoprotein L-fucose levels can be used as an effective biochemical indicator in conjunction with clinical diagnostic procedures in head and neck neoplasia and they may be useful for monitoring recurrences.
Entities:
Keywords:
Head and neck neoplasms; Serum L-fucose glycoprotein; Squamous cell carcinoma
Authors: L Addala; C Kalyana Pentapati; P K Reddy Thavanati; V Anjaneyulu; M D Sadhnani Journal: Indian J Cancer Date: 2012 Apr-Jun Impact factor: 1.224
Authors: Jopi J W Mikkonen; Surya P Singh; Ramin Akhi; Tuula Salo; Reijo Lappalainen; Wilfredo A González-Arriagada; Márcio Ajudarte Lopes; Arja M Kullaa; Sami Myllymaa Journal: Oncol Lett Date: 2018-09-07 Impact factor: 2.967
Authors: P Redwin Dhas Manchil; E Tatu Joy; M Shashi Kiran; J Eugenia Sherubin; M Farakath Khan; B S Aravind Journal: J Pharm Bioallied Sci Date: 2016-10